Vetter is investing 230 million euros in its new production building, which is currently under construction at the global corporate headquarters site in Ravensburg, Germany.

The company recently reached a significant milestone in the construction process, as the shell of the building is now complete, following the start of construction in November 2021. The building is 122m long, 44m wide and 32m tall and will feature several new commercial filling lines to effectively increase aseptic manufacturing capacity for its global customer base. Vetter plans to install the first cleanrooms by the end of 2024.

According to Vetter Managing Director Thomas Otto, "Our new production building signifies our ongoing dedication to support the needs of our customers concerning their complex injectable drug products with regards to packaging systems, specific process requirements and batch sizes. This is just one of several investments we are currently undertaking to manage our sustainable growth."

Further investments include the increase of lab space for analytical services, the expansion of filling capacity through new commercial production lines at other sites in the EU, the expansion in cool storage and warehousing, as well as a new technical equipment warehouse. Added to this are the optimization of infrastructure at all global sites to further develop processes, the development of new compounding and preparation rooms, and as a result, the optimization of the handling incoming and outgoing products.